1CAO X, SUGITA M, VAN DER WEL N, et al, CD1 molecules effi- ciently present antigen in immature dendritic cells and traffic in- dependently of MHC class Ⅱ during dendritic cell maturation [J]. Journal of immunology, 2002, 169(9): 4770-7.
2Lu Y C, Yeh W C, Ohashi P S. LPS/TLR4 signal transduction path-way[J]. Cytokine, 2008, 42(2): 145-151.
3Woltman A M, Op D B M, Biesta P J, et al. Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function[J]. PLoS One, 2011, 6(1): e1 5324.
4Xu Y, Hu Y, Shi B, et al. HBsAg inhibits TLRg-mediated activation and IFN-alpha production in plasmacytoid dendritic ceils[J]. Mol Immunol, 2009, 46(13): 2640-2646.
5Jan R H, Lin Y L, Chen C J, et al. Hepatitis B virus surface antigen can activate human monocyte-derived dendritic cells by nuclear factor kappa B and p38 mitogen-activated protein kinase medi- ated signaling[J]. Microbiol Immunol, 2012, 56{10): 719-727.
6Jan R H, Lin Y L, Chen L K, et al. Hepatitis B virus surface antigen can activate dendritic cells and modulate T helper type immune response[J], Microbiol Immunol, 2011, 55(1 ): 51-59.
7Akbar S M, Furukawa S, Horiike N, et al. Safety and immuno- genicity of hepatitis B surface antigen-pulsed dendritic cells in patients with chronic hepatitis B[J]. J Viral Nepal, 2011, 18(6): 408- 414.
